Skip to main content

Dolomite to Collaborate on EU-funded Microfluidics Tech for Stem Cells

NEW YORK (GenomeWeb News) – UK-based microfluidics developer Dolomite said today that it will collaborate with the Danish firms Bioneer and OptoRobotix in a European Union-funded effort to develop a new stem cell handling device.

The consortium has received €820,100 ($1.1 million) from the EU's Eurostars program to fund the two-year project, which aims to develop a microfluidic tool that could be used in molecular biology, biotechnology, and pharmaceutical applications.

The OPTISORT platform will be a sorting and analysis tool that uses optical and droplet technologies for sorting fragile mammalian cells. It will enable stem cell biology and mammalian cell-based protein manufacturing, which the company said are both fast-developing fields.

OptoRobotix develops flow cytometers with cell sorting capabilities. Bioneer, a subsidiary of the Technical University of Denmark, provides access to tools to facilitate therapeutic, cellular, and molecular biology projects.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.